← Leaderboards
Urs Arnold Ochsner
Crestone, Inc.
$1,724,814
Attributed
$1,724,814
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,724,814 · 2
By mechanism
N01$1,580,854 · 1
R43$143,960 · 1
Top collaborators
No co-investigators on record.
Most similar at Crestone, Inc.
Same institution · by research overlap
- Urs Oschner$8,499,692
- Urs Ochsner$40,390,611
Others in their field
Other Emerging Leaders on “Pathogen”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Thomas Denny · Duke University$42,477,454
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Sujatha Rashid · American Type Culture Collection$37,889,194
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
PathogenAcidsCandidate SelectionAmoxicillinAnti-Bacterial AgentsAntibioticsAntimicrobialAntimicrobial ResistanceBacterial Antibiotic ResistanceBacterial Drug ResistanceBacterial ResistanceBaseBiodefenseBiological MarkersAdvanced DevelopmentCellsChemistryClarithromycinClinical AssessmentsClinical DevelopmentClinical EfficacyClinical ResearchClostridium DifficileAcclimatization